IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4344-4355

  Erbel, Christian ^a   Akhavanpoor, Mohammadreza ^a   Okuyucu, Deniz ^a   Wangler, Susanne ^a   Dietz, Alex ^a   Zhao, Li ^a   Stellos, Konstantinos ^b   Little, Kristina M ^c   Lasitschka, Felix ^a   Doesch, Andreas ^a   Hakimi, Maani ^a   Dengler, Thomas J ^d   Giese, Thomas ^a   Blessing, Erwin ^a   Katus, Hugo A ^a,e   Gleissner, Christian A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c ILLUMINA INC   (United States)

^d Department of Cardiology   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 17; INTERLEUKIN 17 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR 4; TRANSCRIPTOME; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CELL INFILTRATION; CELL LINEAGE; CHEMOTAXIS; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPOPROTEINEMIA TYPE 3; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; TRANSCRIPTOMICS; TREATMENT DURATION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL DIFFERENTIATION; CLUSTER ANALYSIS; COCULTURE; CYTOLOGY; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; FOAM CELL; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIPID METABOLISM; METABOLISM; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; THROMBOCYTE ADHESION;

ANIMALS; ANTIBODIES, MONOCLONAL; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL DIFFERENTIATION; CLUSTER ANALYSIS; COCULTURE TECHNIQUES; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FOAM CELLS; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; LIPID METABOLISM; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; PLATELET ADHESIVENESS; TRANSCRIPTOME;

EID: 84908120736     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400181     Document Type: Article

References (42)

1. ∗). Annu. Rev. Immunol. 27: 165-197.
2. Robbins, C. S., I. Hilgendorf, G. F. Weber, I. Theurl, Y. Iwamoto, J. L. Figueiredo, R. Gorbatov, G. K. Sukhova, L. M. Gerhardt, D. Smyth, et al. 2013. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19: 1166-1172.
3. Gautier, E. L., C. Jakubzick, and G. J. Randolph. 2009. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29: 1412-1418.
4. -/- mice during disease regression. J. Clin. Invest. 121: 2025-2036.
5. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
6. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206: 1549-1564.
7. Erbel, C., L. Chen, F. Bea, S. Wangler, S. Celik, F. Lasitschka, Y. Wang, D. Böckler, H. A. Katus, and T. J. Dengler. 2009. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J. Immunol. 183: 8167-8175.
8. Smith, E., K. M. Prasad, M. Butcher, A. Dobrian, J. K. Kolls, K. Ley, and E. Galkina. 2010. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121: 1746-1755.
9. Chen, S., K. Shimada, W. Zhang, G. Huang, T. R. Crother, and M. Arditi. 2010. IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J. Immunol. 185: 5619-5627.
10. Taleb, S., M. Romain, B. Ramkhelawon, C. Uyttenhove, G. Pasterkamp, O. Herbin, B. Esposito, N. Perez, H. Yasukawa, J. Van Snick, et al. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206: 2067-2077.
11. Gistera, A., A. K. Robertson, J. Andersson, D. F. Ketelhuth, O. Ovchinnikova, S. K. Nilsson, A. M. Lundberg, M. O. Li, R. A. Flavell, and G. K. Hansson. 2013. Transforming Growth Factor-beta Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17-Dependent Pathway. Sci. Transl. Med. 5: 196ra100.
12. de Boer, O. J., J. J. van der Meer, P. Teeling, C. M. van der Loos, M. M. Idu, F. van Maldegem, J. Aten, and A. C. van der Wal. 2010. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J. Pathol. 220: 499-508.
13. Erbel, C., T. J. Dengler, S. Wangler, F. Lasitschka, F. Bea, N. Wambsganss, M. Hakimi, D. Böckler, H. A. Katus, and C. A. Gleissner. 2011. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res. Cardiol. 106: 125-134.
14. Celik, S., H. Langer, K. Stellos, A. E. May, V. Shankar, K. Kurz, H. A. Katus, M. P. Gawaz, and T. J. Dengler. 2007. Platelet-associated LIGHT (TNFSF14) mediates adhesion of platelets to human vascular endothelium. Thromb. Haemost. 98: 798-805.
15. Jain, N., J. Thatte, T. Braciale, K. Ley, M. O'Connell, and J. K. Lee. 2003. Localpooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 19: 1945-1951.
16. Gleissner, C. A., I. Shaked, C. Erbel, D. Böckler, H. A. Katus, and K. Ley. 2010. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ. Res. 106: 203-211.
17. Jain, N., H. Cho, M. O'Connell, and J. K. Lee. 2005. Rank-invariant resampling based estimation of false discovery rate for analysis of small sample microarray data. BMC Bioinformatics 6: 187.
18. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102: 15545-15550.
19. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311.
20. Gleissner, C. A., I. Shaked, K. M. Little, and K. Ley. 2010. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J. Immunol. 184: 4810-4818.
21. Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37 (Suppl. 1): S9-S17.
22. Pöllinger, B., T. Junt, B. Metzler, U. A. Walker, A. Tyndall, C. Allard, S. Bay, R. Keller, F. Raulf, F. Di Padova, et al. 2011. Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J. Immunol. 186: 2602-2612.
23. Niessner, A., M. S. Shin, O. Pryshchep, J. J. Goronzy, E. L. Chaikof, and C. M. Weyand. 2007. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 116: 2043-2052.
24. Danzaki, K., Y. Matsui, M. Ikesue, D. Ohta, K. Ito, M. Kanayama, D. Kurotaki, J. Morimoto, Y. Iwakura, H. Yagita, et al. 2012. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32: 273-280.
25. Butcher, M. J., B. N. Gjurich, T. Phillips, and E. V. Galkina. 2012. The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ. Res. 110: 675-687.
26. Madhur, M. S., S. A. Funt, L. Li, A. Vinh, W. Chen, H. E. Lob, Y. Iwakura, Y. Blinder, A. Rahman, A. A. Quyyumi, and D. G. Harrison. 2011. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31: 1565-1572.
27. Okamoto, Y., M. Hasegawa, T. Matsushita, Y. Hamaguchi, D. L. Huu, Y. Iwakura, M. Fujimoto, and K. Takehara. 2012. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum. 64: 3726-3735.
28. Gregersen, I., M. Skjelland, S. Holm, K. B. Holven, K. Krogh-Sørensen, D. Russell, E. T. Askevold, C. P. Dahl, S. Ørn, L. Gullestad, et al. 2013. Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis. PLoS ONE 8: e72769.
29. Eid, R. E., D. A. Rao, J. Zhou, S. F. Lo, H. Ranjbaran, A. Gallo, S. I. Sokol, S. Pfau, J. S. Pober, and G. Tellides. 2009. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119: 1424-1432.
30. Cheng, X., X. Yu, Y. J. Ding, Q. Q. Fu, J. J. Xie, T. T. Tang, R. Yao, Y. Chen, and Y. H. Liao. 2008. The Th17/Treg imbalance in patients with acute coronary syndrome. [Published erratum appears in 2009 Clin. Immunol. 133: 447.] Clin. Immunol. 127: 89-97.
31. Simon, T., S. Taleb, N. Danchin, L. Laurans, B. Rousseau, S. Cattan, J. M. Montely, O. Dubourg, A. Tedgui, S. Kotti, and Z. Mallat. 2013. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur. Heart J. 34: 570-577.
32. Shimada, M., A. Andoh, K. Hata, K. Tasaki, Y. Araki, Y. Fujiyama, and T. Bamba. 2002. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J. Immunol. 168: 861-868.
33. Llodrá, J., V. Angeli, J. Liu, E. Trogan, E. A. Fisher, and G. J. Randolph. 2004. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 101: 11779-11784.
34. Williams, K. J., J. E. Feig, and E. A. Fisher. 2008. Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat. Clin. Pract. Cardiovasc. Med. 5: 91-102.
35. Moore, K. J., and I. Tabas. 2011. Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355.
36. Zizzo, G., and P. L. Cohen. 2013. IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J. Immunol. 190: 5237-5246.
37. Bouhlel, M. A., B. Derudas, E. Rigamonti, R. Dièvart, J. Brozek, S. Haulon, C. Zawadzki, B. Jude, G. Torpier, N. Marx, et al. 2007. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6: 137-143.
38. Waldo, S. W., Y. Li, C. Buono, B. Zhao, E. M. Billings, J. Chang, and H. S. Kruth. 2008. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172: 1112-1126.
39. Xu, X. H., P. K. Shah, E. Faure, O. Equils, L. Thomas, M. C. Fishbein, D. Luthringer, X. P. Xu, T. B. Rajavashisth, J. Yano, et al. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104: 3103-3108.
40. Kadowaki, N., S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869.
41. Methe, H., J. O. Kim, S. Kofler, M. Weis, M. Nabauer, and J. Koglin. 2005. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 111: 2654-2661.
42. Michelsen, K. S., M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101: 10679-10684.